Injection drug use and human immunodeficiency virus infection.
about
Methadone enhances human immunodeficiency virus infection of human immune cellsModeling the Effects of Morphine on Simian Immunodeficiency Virus DynamicsRhesus macaque model of chronic opiate dependence and neuro-AIDS: longitudinal assessment of auditory brainstem responses and visual evoked potentialsMethadone treatment protects against HIV infection: two decades of experience in the Bronx, New York City.Cross sectional analysis of respiratory symptoms in an injection drug user cohort: the impact of obstructive lung disease and HIV.Methylnaltrexone antagonizes opioid-mediated enhancement of HIV infection of human blood mononuclear phagocytesNot all injection drug users are created equal: heterogeneity of HIV, hepatitis C virus, and hepatitis B virus infection in Georgia.Morphine enhances HIV infection of human blood mononuclear phagocytes through modulation of beta-chemokines and CCR5 receptor.Accelerated evolution of SIV env within the cerebral compartment in the setting of morphine-dependent rapid disease progressionHarm reduction theories and strategies for control of human immunodeficiency virus: a review of the literature.Morphine suppresses IFN signaling pathway and enhances AIDS virus infection.Frequent food insecurity among injection drug users: correlates and concerns.Prevalence and risk factors for unrecognized obstructive lung disease among urban drug users.Inhibition of anti-HIV microRNA expression: a mechanism for opioid-mediated enhancement of HIV infection of monocytesDrugs of abuse and HIV infection/replication: implications for mother-fetus transmission.Variable region 4 of SIV envelope correlates with rapid disease progression in morphine-exposed macaques infected with SIV/SHIV.Drug interactions associated with methadone, buprenorphine, cocaine, and HIV medications: implications for pregnant women.Cross sectional study of factors associated to self-reported blood-borne infections among drug users.Cocaine promotes both initiation and elongation phase of HIV-1 transcription by activating NF-κB and MSK1 and inducing selective epigenetic modifications at HIV-1 LTRHeroin inhibits HIV-restriction miRNAs and enhances HIV infection of macrophages.Clinical care of the HIV-infected drug userThe social determinants of emergency department and hospital use by injection drug users in Canada.Obstructive Lung Diseases in HIV: A Clinical Review and Identification of Key Future Research Needs.Modulation by morphine of viral set point in rhesus macaques infected with simian immunodeficiency virus and simian-human immunodeficiency virus.Opioids and HIV/HCV infection.Health-Related Quality of Life in HIV-Infected and At-Risk Women: The Impact of Illicit Drug Use and Hepatitis C on a Community Preference Weighted Measure.Disproportionate impact of combination antiretroviral therapy on AIDS incidence in Australia: results from a modified back-projection model.Effect of morphine on the neuropathogenesis of SIVmac infection in Indian Rhesus Macaques."Shotgunning" in a population of patients with severe mental illness and comorbid substance use disorders.
P2860
Q28344125-0A03AF62-4E8B-4CEC-8A56-F2EE87A0D5D0Q28554352-4B4C3682-7765-4210-AC4F-96CF60CC3627Q30452156-ABB21993-63F8-4E54-864D-223551EDABC5Q32030710-898B9D9D-CB4D-43C4-BA5F-1B83D4A85790Q33575488-64520582-25AF-4E71-AE24-7302B0C8D906Q33593875-021E47EA-78A8-49E1-A680-ECBFD8CE48BEQ33673340-4ED7E135-4C0E-47CB-91CB-CEF2A7F595EBQ33683180-8AB543D8-E66B-4B79-948C-F831BE49FC9CQ33688391-959C35E5-FA7A-47CB-A905-8EC97802A7D0Q33938301-A20DFD8F-6DBE-4BC7-A5C8-A84C9AFEA6CDQ34168153-70594E2D-6F15-43C2-ABF7-B371F73B9A54Q34502479-E2A04DA3-D171-4F09-84CB-679C97C17B74Q34621075-E4993E01-73FA-4914-9384-68F0EFCC919DQ34756351-9F1E589B-1312-4B69-9096-2583314FA34DQ35000656-399F9F78-128B-49D3-A0EE-846BDDDE8F5DQ35282021-8E4852F0-2F99-4D9F-8579-645D6EFCF31DQ35738851-DE635120-3FFD-49F8-9048-701C41F2B2DFQ35841089-8C0288B9-8C4D-439D-8F84-84314AC11E50Q35894061-AB0D46DB-3682-47D0-AA63-36F46DBB4207Q36245718-E0589626-38B5-4D48-9AB2-F7420F282014Q36248580-B74B0C94-14E8-40FF-A909-0F2EDC1BF8EEQ36274713-B5DD9B40-5314-47C8-AF7E-1E2CA98678C8Q36733646-20A156CA-A029-498E-813D-BAE28DFB9409Q37567921-D0F5F213-33EE-4B78-928C-58AE9E3BF4A1Q37607856-01B94946-D64F-4DE7-9F8F-70946F13A958Q37693067-F5E5B3AE-1A09-4D61-AACF-4708252A82B3Q43549723-75CD5C6B-B329-4CC1-AFDE-3D3C0D06754DQ46774066-07051174-B7D5-4FEB-96EE-C61A088A39CBQ50769084-7EF49844-1C54-4694-85BC-233F80F65F89
P2860
Injection drug use and human immunodeficiency virus infection.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Injection drug use and human immunodeficiency virus infection.
@en
type
label
Injection drug use and human immunodeficiency virus infection.
@en
prefLabel
Injection drug use and human immunodeficiency virus infection.
@en
P356
P1476
Injection drug use and human immunodeficiency virus infection.
@en
P2093
Friedland G
P304
P356
10.1093/CLINIDS/20.6.1467
P407
P577
1995-06-01T00:00:00Z